Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Berg patents

Patents where

Current Assignee

Name

Berg

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11400058 Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof	Patent 11400058 was granted and assigned to Berg on August, 2022 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	11400058	August 2, 2022
‌ US Patent 11305016 Vitamin D3 and analogs thereof for treating alopecia		Berg	Berg	United States Patent and Trademark Office	11305016	April 19, 2022
‌ US Patent 11298313 Methods of treatment of cancer by continuous infusion of coenzyme Q10	Patent 11298313 was granted and assigned to Berg on April, 2022 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11298313	April 12, 2022
‌ US Patent 11419830 Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa		Berg	Berg	United States Patent and Trademark Office	11419830	August 23, 2022
‌ US Patent 10519504 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers	Patent 10519504 was granted and assigned to Berg on December, 2019 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	10519504	December 31, 2019
‌ US Patent 11028446 Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)	Patent 11028446 was granted and assigned to Berg on June, 2021 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11028446	June 8, 2021
‌ US Patent 10352947 Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease	Patent 10352947 was granted and assigned to Berg on July, 2019 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10352947	July 16, 2019
‌ US Patent 11209422 Methods and kits for detection of coenzyme Q10	Patent 11209422 was granted and assigned to Berg on December, 2021 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11209422	December 28, 2021
‌ US Patent 10188707 Enolase 1 (Eno1) compositions and uses thereof	Patent 10188707 was granted and assigned to Berg on January, 2019 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10188707	January 29, 2019
‌ US Patent 11224641 Enolase 1 (ENO1) compositions and uses thereof	Patent 11224641 was granted and assigned to Berg on January, 2022 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11224641	January 18, 2022
‌ US Patent 10188708 Enolase 1 (Eno1) compositions and uses thereof	Patent 10188708 was granted and assigned to Berg on January, 2019 by the United States Patent and Trademark Office.	Berg (company)	Berg	United States Patent and Trademark Office	10188708	January 29, 2019
‌ US Patent 10114013 Method for detection of coenzyme Q10	Patent 10114013 was granted and assigned to Berg on October, 2018 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10114013	October 30, 2018
‌ US Patent 11091447 UBE2K modulators and methods for their use	Patent 11091447 was granted and assigned to Berg on August, 2021 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11091447	August 17, 2021
‌ US Patent 10376477 Method of treating or preventing tumors of the central nervous system	Patent 10376477 was granted and assigned to Berg on August, 2019 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10376477	August 13, 2019
‌ US Patent 10933032 Methods for the treatment of cancer using coenzyme Q10 combination therapies	Patent 10933032 was granted and assigned to Berg on March, 2021 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10933032	March 2, 2021
‌ US Patent 10482385 Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data	Patent 10482385 was granted and assigned to Berg on November, 2019 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10482385	November 19, 2019
‌ US Patent 10973763 Inhalable pharmaceutical compositions	Patent 10973763 was granted and assigned to Berg on April, 2021 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	10973763	April 13, 2021
‌ US Patent 10365279 Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy	Patent 10365279 was granted and assigned to Berg on July, 2019 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	10365279	July 30, 2019
‌ US Patent 10668028 Methods and use of inducing apoptosis in cancer cells	Patent 10668028 was granted and assigned to Berg on June, 2020 by the United States Patent and Trademark Office.	Berg (company)	Berg	United States Patent and Trademark Office	10668028	June 2, 2020
‌ US Patent 10539566 Use of markers including filamin A in the diagnosis and treatment of prostate cancer	Patent 10539566 was granted and assigned to Berg on January, 2020 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10539566	January 21, 2020
‌ US Patent 11001891 Methods for treating Parkinson's disease	Patent 11001891 was granted and assigned to Berg on May, 2021 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	11001891	May 11, 2021
‌ US Patent 10588859 Topical formulations having enhanced bioavailability	Patent 10588859 was granted and assigned to Berg on March, 2020 by the United States Patent and Trademark Office.	Berg	Berg	United States Patent and Trademark Office	10588859	March 17, 2020
‌ US Patent 10759850 Filamin A binding proteins and uses thereof	Patent 10759850 was granted and assigned to Berg on September, 2020 by the United States Patent and Trademark Office.	Berg (company)	Berg	United States Patent and Trademark Office	10759850	September 1, 2020
‌ US Patent 10061887 Interrogatory cell-based assays and uses thereof	Patent 10061887 was granted and assigned to Berg on August, 2018 by the United States Patent and Trademark Office.		Berg	United States Patent and Trademark Office	10061887	August 28, 2018
‌ US Patent 11694765 Interrogatory cell-based assays for identifying drug-induced toxicity markers		Berg	Berg	United States Patent and Trademark Office	11694765	July 4, 2023

Results per page:

25 results

0 selected

25 results

0 selected